NAMENDA XR

Peak

memantine hydrochloride

NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jun 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1

Clinical Trials (1)

NCT02162251N/ACompleted

Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease

Started Jun 2013
3,482 enrolled
Alzheimer's Desease

Loss of Exclusivity

LOE Date
Sep 24, 2029
43 months away
Patent Expiry
Sep 24, 2029

Patent Records (2)

Patent #ExpiryTypeUse Code
8039009
Mar 24, 2029
U-539
8039009*PED
Sep 24, 2029